Performance of computer-assisted continuous infusion at low concentrations of intravenous sedatives

Anesthesia and Analgesia

Volumn 84, Issue 5, 1997, Pages 1049-1057

  Veselis, Robert A ^a,b   Glass, Peter ^c   Dnistrian, Ann ^a   Reinsel, Ruth ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b Department of Obstetrics Gynecology   (United States)

^c DUKE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MIDAZOLAM; PROPOFOL; SEDATIVE AGENT; THIOPENTAL;

ANESTHESIA INDUCTION; ARTERIAL BLOOD; ARTICLE; BLOOD SAMPLING; CALCULATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; DRUG BLOOD LEVEL; FEMALE; HUMAN; INTERMETHOD COMPARISON; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEDATION; STATISTICAL ANALYSIS; STEADY STATE; VENOUS BLOOD;

EID: 0030912051     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-199705000-00018     Document Type: Article

References (27)

1. Glass PSA, Jacobs JR, Quill TJ. Intravenous drug delivery systems. In: Fragen RJ, ed. Drug infusions in anesthesiology. New York: Raven Press, 1991:23-61.
2. Glass PSA, Shafer SL, Jacobs JR, Reves JG. Intravenous drug delivery systems. In: Miller R, ed. Anesthesia. New York: Churchill Livingstone, 1994:389-416.
3. Egan TD. Intravenous drug delivery systems: toward an intravenous "vaporizer". J Clin Anesth 1996;8:8S-14S.
4. McClain DA, Hug CJ. Intravenous fentanyl kinetics. Clin Pharmacol Ther 1980;28:106-14.
5. White PF. Intravenous anesthesia and analgesia: what is the role of target-controlled infusion? J Clin Anesth 1996;8:26S-28S.
6. Peacock JE, Blackburn A, Sherry KM, Reilly CS. Arterial and jugular venous bulb blood propofol concentrations during induction of anesthesia. Anesth Analg 1995;80:1002-6.
7. Hughes MA, Glass PS, Jacobs JR. Context-sensitive half-time in multicompartment pharmacokinetic models for intravenous anesthetic drugs. Anesthesiology 1992;76:334-41.
8. Ausems ME, Stanski DR, Hug CC. An evaluation of the accuracy of pharmacokinetic data for the computer assisted infusion of alfentanil. Br J Anaesth 1985;57:1217-25.
9. Shafer SL, Varvel JR, Aziz N, Scott JC. Pharmacokinetics of fentanyl administered by computer-controlled infusion pump. Anesthesiology 1990;73:1091-102.
10. Glass PS, Jacobs JR, Smith LR, et al. Pharmacokinetic model-driven infusion of fentanyl: assessment of accuracy. Anesthesiology 1990;73:1082-90.
11. Buhrer M, Maitre PO, Hung OR, et al. Thiopental pharmacodynamics. I. Defining the pseudo steady state serum concentraion EEG effect relationship. Anesthesiology 1992;77:226-36.
12. Coetzee JF, Glen JB, Wium CA, Boshoff L. Pharmacokinetic model selection for target controlled infusions of propofol. Assessment of three parameter sets. Anesthesiology 1995;82: 1328-45.
13. Gepts E, Camu F, Cockshott ID, Douglas EJ. Disposition of propofol administered as constant rate intravenous infusions in humans. Anesth Analg 1987;66:1256-63.
14. Greenblatt DJ, Abernathy DR, Lockniskar A, et al. Effect of age, gender, and obesity on midazolam kinetics. Anesthesiology 1984;61:27-35.
15. Ghoneim MM, Van HM. Pharmacokinetics of thiopentone: effects of enflurane and nitrous oxide anaesthesia and surgery. Br J Anaesth 1978;50:1237-42.
16. Rudman D. Assessment of nutritional status. In: Braunwald E, Isselbacher KJ, Petersdorf RG, et al., eds. Harrison's principles of internal medicine. 11 ed. Vol. 1. New York: McGraw-Hill, 1987:390-3.
17. Varvel JR, Donoho DL, Shafer SL. Measuring the predictive performance of computer-controlled infusion pumps. J Pharmacokinet Biopharm 1992;20:63-94.
18. Shafer SL. Constant versus optimal plasma concentrations [editorial; comment]. Anesth Analg 1993;76:467-9.
19. Chiou WL. The phenomenon and rationale of marked dependence of drug concentration on blood sampling site. Implications in pharmacokinetics, pharmacodynamics, toxicology and therapeutics (part II). Clin Pharmacokinet 1989;17:275-90.
20. Chiou WL. The phenomenon and rationale of marked dependence of drug concentration on blood sampling site. Implications in pharmacokinetics, pharmacodynamics, toxicology and therapeutics (part I). Clin Pharmacokinet 1989;17:175-99.
21. Scott JC, Stanski DR. Decreased fentanyl and alfentanil dose requirements with age. A simultaneous pharmacokinetic and pharmacodynamic evaluation. J Pharmacol Exp Ther 1987;240: 159-66.
22. Wang YP, Cheng YJ, Fan SZ, Liu CC. Arteriovenous concentration differences of propofol during and after a stepdown infusion. Anesth Analg 1994;79:1148-50.
23. Woestenborghs RJ, Stanski DR, Scott JC, Heykants JJ. Assay methods for fentanyl in serum: gas-liquid chromatography versus radioimmunoassay. Anesthesiology 1987;67:85-90.
24. Celardo A, Bonati M. Determination of thiopental measured in human blood by reversed-phase high-performance liquid chromatography. J Chromatogr 1990;527:220-5.
25. Crankshaw DP, Boyd MD, Bjorksten AR. Plasma drug efflux - a new approach to optimization of drug infusion for constant blood concentration of thiopental and methohexital. Anesthesiology 1987;67:32-41.
26. Vree TB, Baars AM, de Grood PM. High-performance liquid chromatographic determination and preliminary pharmacokinetics of propofol and its metabolites in human plasma and urine. J Chromatogr 1987;417:458-64.
27. Puglisi CV, Pao J, Ferrara FJ, de Silva JA. Determination of midazolam (Versed) and its metabolites in plasma by high-performance liquid chromatography. J Chromatogr 1985;344: 199-209.